<DOC>
	<DOC>NCT00619840</DOC>
	<brief_summary>Investigation of efficacy and tolerability of extended-release MPD in adults with ADHD, compared with a placebo, and to acquire knowledge through long-term observation of adults</brief_summary>
	<brief_title>Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<criteria>Patient treated as outpatient or inpatient Patient has a good command of German Score of 85 or greater in the IQ test (MWTB) Diagnosis of ADHD according to ADHDCL (DSM IV) and WRIWRAADDS &gt; 28 points ADHD symptoms have existed since childhood (WURSk &gt;= 30) Body mass index &gt;= 20 Willing to eat breakfast Patient is willing and able to come to the observation appointments Written consent of the patient to participate in the study Treatment with psychostimulants in the past 2 weeks Inconsistencies in the CAARS S:L &gt;= 8 (Inconsistency Index) Shift work or night work Alcohol, medication or drug dependency in the past 6 months or manifest drug abuse Diagnosis of a psychosis (SKIDI) Epileptic attacks in the past EEG results which suggest epilepsy Clinically relevant liver disease Clinically relevant hyperthyroidism (relevantly elevated TSH, T4) Acute depressive episode according to ICD10 F32.2 and ICD10 32.3 (SKIDI) Illnesses with schizophrenic symptoms (SKIDI) Acute manic episode, bipolar disorder (SKIDI) Diagnosis of a tic disorder Acute anorexia Acute prominent panic disorder and generalised anxiety (SKIDI) Clinically relevant kidney disorders Known high blood pressure Known occlusive arterial disease Known angina pectoris Known coronary heart disease and state after myocardial infarction Known tachycardial arrhythmias Poststroke status Known elevated intraoccular pressure Known enlarged prostates Participation in a clinical study within the past 30 days Participation in this study at an earlier point in time Simultaneous participation in another clinical trial Women of childbearing age without adequate contraception Patients with terminal illness (e.g. cancer) Pregnancy (positive pregnancy test) or lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>adult</keyword>
	<keyword>methylphenidate hydrochloride</keyword>
	<keyword>Medikinet retard</keyword>
	<keyword>long-term observation</keyword>
	<keyword>controlled clinical trial</keyword>
	<keyword>safety</keyword>
	<keyword>randomized, double-blind, placebo-controlled trial</keyword>
	<keyword>treatment</keyword>
	<keyword>central nervous system stimulants</keyword>
	<keyword>therapeutic uses</keyword>
</DOC>